Stephen Hohmann, MD
Vascular Surgery · Dallas, TXNPI 1114020922
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 78.2% of it on its own, with 51 other manufacturers making up the rest. Reporting peaked in 2021 at $158,000 and has fallen 78.3% since, to $34,330 in 2025. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 566 payments — averaging $881.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$390K
- Merit Medical Systems Inc$68K
- Medtronic$18K
- C. R. Bard, Inc. & Subsidiaries$14K
- W. L. Gore & Associates, Inc.$4K
- Mozarc Medical US LLC$1K
- plus $5K from 46 others
Across 29 payments — averaging $3054.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merit Medical Systems Inc$66K
- Bard Peripheral Vascular, Inc.$22K
- Medtronic$350
- Sonavex, Inc.$52
What the payments were for
- Consulting fees$268,46154%
- Speaking & faculty fees$186,51837%
- Grants$1,1340%
- Travel & lodging$25,8175%
- Food & beverage$13,6663%
- Education$3,4331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WAVELINQ$117,450
- HeRO Graft$11,000
- Surfacer Inside-Out Catheter$7,500
- Wrapsody Stent Graft$6,340
- IN.PACT Admiral$6,083
- Peritoneal Dialysis Systems$4,492
- ELLIPSYS VASCULAR ACCESS SYSTEM$4,200
- GORE VIABAHN Endoprosthesis with Heparin$2,860
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$2,860
- GORE PROPATEN Vascular Graft$2,860
- Palindrome$900
- TurboHawk$749
- Product in Development$440
- EchoMark$342
- EchoSure$342
- IN.PACT AV$325
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$304
- Abre$282
- METACROSS OTW$181
- Azur CX Detachable$181
How this compares
$499,029 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 37 | $33,155 |
| ClopidogrelClopidogrel Bisulfate | 53 | $500 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $122 |
| Tramadol Hcl | 39 | $79 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $112 | $33,15537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Dallas
- Gregory PearlDallas$2.3M
- Michael SiahDallas$392K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Alton BurnsDallas$98K
- John EidtDallas$88K
- Babafemi PrattDallas$87K
- Marc SalhanickDallas$84K
- Bradley GrimsleyDallas$78K
- William ShutzeDallas$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.